Total population |
800 |
(100) |
Subjects with at least one TEAE |
159 |
(19.9) |
Subjects with ...1 TEAE |
119 |
(14.9) |
...2 TEAEs |
33 |
(4.1) |
..3 TEAEs |
7 |
(0.9) |
Nervous system disorders |
52 |
(6.5) |
Dysgeusia |
23 |
(2.9) |
Dizziness |
10 |
(1.3) |
Drowsiness |
6 |
(0.8) |
Somnolence |
5 |
(0.6) |
Headache |
3 |
(0.4) |
Memory impairment |
3 |
(0.4) |
Disturbance in attention |
2 |
(0.3) |
Gastrointestinal disorders |
42 |
(5.3) |
Nausea |
10 |
(1.3) |
Dry mouth |
14 |
(1.8) |
Mouth discomfort |
9 |
(1.1) |
Vomiting |
6 |
(0.8) |
Diarrhea |
2 |
(0.3) |
Oral pain |
1 |
(0.1) |
General disorders and administration site conditions |
23 |
(2.9) |
Feeling abnormal |
9 |
(1.1) |
Fatigue |
8 |
(1.0) |
Application site pain |
6 |
(0.8) |
Psychiatric disorders |
16 |
(2.0) |
Disorientation |
6 |
(0.8) |
Depressed mood |
5 |
(0.6) |
Confusion |
4 |
(0.5) |
Anxiety |
1 |
(0.1) |
Metabolism and nutrition disorders |
56 |
(7.0) |
Increased appetite |
50 |
(6.3) |
Anorexia |
6 |
(0.8) |
Respiratory, thoracic and mediastinal disorders |
17 |
(2.1) |
Pharyngolaryngeal pain |
14 |
(1.8) |
Dyspnoea |
3 |
(0.4) |
Total number of TEAEs |
206 |
(100) |
Metabolism and nutrition disorders |
56 |
(27.2) |
Nervous system disorders |
52 |
(25.2) |
Gastrointestinal disorders |
42 |
(20.4) |
General disorders and administration site conditions |
23 |
(11.2) |
Respiratory, thoracic and mediastinal disorders |
17 |
(8.3) |
Psychiatric disorders |
16 |
(7.8) |
TEAE intensity …mild |
168 |
(81.6) |
…moderate |
34 |
(16.5) |
…severe |
4 |
(1.9) |
TEAE-related treatment discontinuations (pats.) |
32 |
(4.0) |
Discontinuation due to …dysgeusia |
14 |
(1.8) |
…dizziness |
6 |
(0.8) |
…fatigue |
6 |
(0.8) |
…mouth discomfort |
4 |
(0.5) |
…somnolence |
2 |
(0.3) |
Efficacy-related treatment discontinuations (pats.) |
113 |
(14.1) |
Treatment discontinuations for any reasons (pats.) |
145 |
(18.1) |